241 results
Page 8 of 13
8-K
EX-99.1
9a4bt8ni6
28 Oct 13
BioTime Reports Interim Results on Renevia™ Clinical Safety Trial
12:00am
DEFA14A
r7e2vi5sszx1l31gs6
7 Oct 13
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
6zawocu4ak0 msqi5hkh
4 Oct 13
BioTime Announces Additional Products in Development Based on HyStem® Technology
12:00am
8-K
xo0jgx0jszi7xw69 qf
4 Oct 13
BioTime Announces Additional Products in Development Based on HyStem® Technology
12:00am
8-K
EX-99.1
cfrzipzhz6tetbl
1 Oct 13
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron’s Embryonic Stem Cell Assets
12:00am
8-K
EX-99.1
nyx2vidkuuxpt
28 Aug 13
BioTime Receives Approval to Begin Human Clinical Trials of Renevia
12:00am
8-K
upe4w3kt y7z1ltox
28 Aug 13
BioTime Receives Approval to Begin Human Clinical Trials of Renevia
12:00am
424B3
j4hpu
2 Aug 13
Prospectus supplement
12:00am
8-K
EX-99.1
am5ui
10 Jan 13
BioTime Submits Protocol for Initiation of Human Clinical Trials of Renevia™ in Europe
12:00am
DEFA14A
EX-2.1
w16eofh
8 Jan 13
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
xqs8v6e4z9u3y8ou
8 Jan 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
hqw4p3d
18 Dec 12
BioTime Reports Isolation of Seven Diverse Cartilage and Bone Cell Types From Human Embryonic Stem Cells
12:00am
8-K
EX-99.1
lx20r7c23fty6kfhu8pn
4 Dec 12
BioTime CEO Dr. Michael West Presents Product Development Update at World Stem Cell Summit 2012
12:00am